Mark Fishman

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Mark Fishman
Residence United States
Alma mater Yale College, Harvard Medical School
Known for pioneering Zebrafish research in cardiology
Awards Institute of Medicine member, Fellow of the American Academy of Arts and Sciences
Scientific career
Fields Medicine, Cardiology
Institutions Novartis Institutes of BioMedical Research, Massachusetts General Hospital, Harvard Medical School

Mark Fishman is an American cardiologist. A researcher and clinician in cardiology, he is the previous President of the Novartis Institutes for BioMedical Research (NIBR),[1] the main research arm of Novartis Pharmaceuticals.[2]

Fishman was appointed President of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.[3] He is the author of over 100 publications[4] and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.[5][6][7]



He was previously a Professor of Medicine at Harvard Medical School, Chief of Cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.[8]

After being the head of Novartis for 13 years, he has decided to retire in 2016.[9]


External links[edit]